Source: Alpha Cognition.
Market Herald logo

Subscribe

Be the first with the news that moves the market
  • Alpha Cognition (ACOG) has withdrawn its marketed public offering
  • Current market conditions were deemed not conducive to an offering on terms that would be in the best interests of the company’s stockholders
  • Alpha Cognition is a clinical-stage biopharmaceutical company developing treatments for underserved neurodegenerative diseases
  • Alpha Cognition Inc. (ACOG) is down 10 per cent on the day, trading at C$0.36 per share at 1:45 pm ET

Alpha Cognition (ACOG) has withdrawn its previously-announced marketed public offering.

The company’s management determined that current market conditions are not conducive to an offering on terms that would be in the best interests of the company’s stockholders.

No securities will be sold pursuant to the offering.

Alpha Cognition is a clinical-stage biopharmaceutical company developing treatments for underserved neurodegenerative diseases.

Alpha Cognition Inc. (ACOG) is down 10 per cent on the day, trading at C$0.36 per share at 1:45 pm ET.


More From The Market Herald

" @ the Bell: Tech leads TSX comeback

It was another rocky day for Canada’s main stock index that ultimately ended up in the green thanks to a lead powered by
Geomega Resources - President & CEO, Kiril Mugerman

" Geomega Resources (TSXV:GMA) granted $3M for recycling demo plant

Geomega Resources (GMA) has been awarded a $3 million grant from the government of Quebec’s Technoclimat Program.
First Hydrogen Corp. - CEO of Automotive, Steve Gill.

" First Hydrogen (TSXV:FHYD) unveils next gen FCEV images

First Hydrogen (FHYD) has received the initial Generation II images for its hydrogen fuel cell vehicle (FCEV), designed in collaboration with EDAG Group.
The Tugaske Project.

" Gensource Potash (TSXV:GSP) closes non-brokered private placement

Gensource Potash Corporation (GSP) has closed its previously announced non-brokered private placement of units and flow-through common shares.